Yuchao Lu Selected Research

Bone Morphogenetic Protein 2

1/2022	Role of Nox4 in High Calcium-Induced Renal Oxidative Stress Damage and Crystal Deposition.
3/2015	Calcium ions promote primary renal epithelial cell differentiation into cells with bone-associated phenotypes via transforming growth factor-β1-induced epithelial-mesenchymal transition in idiopathic hypercalciuria patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuchao Lu Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 07/2016
6	Hypercalciuria 01/2022 - 02/2014
5	Nephrolithiasis 01/2019 - 03/2015
4	Urolithiasis 01/2022 - 01/2016
4	Fever (Fevers) 11/2017 - 01/2015
3	Kidney Calculi (Kidney Stone) 01/2022 - 04/2020
3	Hyperoxaluria (Oxaluria) 01/2021 - 01/2018
3	Inflammation (Inflammations) 01/2021 - 01/2018
2	Pain (Aches) 11/2021 - 01/2019
2	Postoperative Pain 11/2021 - 11/2017
2	Pathologic Constriction (Stenosis) 01/2020 - 01/2019
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2019 - 01/2017
2	Urinary Calculi (Urinary Calculus) 01/2018 - 03/2017
1	Necrosis 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Choristoma (Ectopic Tissue) 01/2021
1	Carcinogenesis 11/2020
1	Neoplasm Metastasis (Metastasis) 11/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Obesity 11/2018
1	Overweight 11/2018
1	Cysts 10/2017
1	Hematuria 01/2017
1	Urinary Tract Infections (Urinary Tract Infection) 04/2016
1	Pneumothorax 04/2016
1	Sepsis (Septicemia) 04/2016
1	Hypotension (Low Blood Pressure) 01/2015
1	Nausea 01/2015
1	Vomiting 01/2015

Drug/Important Bio-Agent (IBA)

6	CalciumIBA 01/2022 - 03/2015
4	OxalatesIBA 01/2021 - 01/2017
2	Calcitriol (Calcijex)FDA LinkGeneric 01/2022 - 02/2014
2	Oxidoreductases (Dehydrogenase)IBA 01/2022 - 11/2020
2	Bone Morphogenetic Protein 2IBA 01/2022 - 03/2015
2	NADP (NADPH)IBA 01/2022 - 01/2019
2	Calcium OxalateIBA 01/2021 - 01/2018
2	Messenger RNA (mRNA)IBA 11/2020 - 01/2016
2	Galactose (Galactopyranose)FDA LinkGeneric 05/2017 - 07/2016
2	pillar(5)areneIBA 05/2017 - 07/2016
2	Analgesics (Analgesic Drugs)IBA 04/2016 - 01/2015
1	CaspasesIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Anesthetics (Anesthetic Agents)IBA 11/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	UbiquitinIBA 01/2021
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2021
1	Lysine (L-Lysine)FDA Link 11/2020
1	ProdrugsIBA 01/2020
1	Dimethyl FumarateIBA 01/2019
1	Oxidants (Oxidizing Agents)IBA 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	Uric Acid (Urate)IBA 11/2018
1	SodiumIBA 11/2018
1	Losartan (Cozaar)FDA LinkGeneric 01/2018
1	ElementsIBA 01/2018
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2018
1	Hemoglobins (Hemoglobin)IBA 11/2017
1	ThuliumIBA 10/2017
1	Vitamin D FDA LinkGeneric 03/2017
1	hydroxide ionIBA 03/2017
1	MitoTEMPOIBA 01/2017
1	AntioxidantsIBA 01/2017
1	ferrocenecarboxylic acid (ferrocene carboxylic acid)IBA 07/2016
1	MetalsIBA 04/2016
1	NF-kappa B (NF-kB)IBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Biological ProductsIBA 01/2016
1	IonsIBA 03/2015
1	OsteopontinIBA 03/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2015
1	Calcitriol Receptors (Calcitriol Receptor)IBA 02/2014

Therapy/Procedure

5	Operative Time 11/2021 - 01/2015
4	Length of Stay 11/2021 - 04/2016
3	Therapeutics 01/2022 - 10/2017
3	Blood Transfusion (Blood Transfusions) 11/2017 - 01/2015
2	Analgesia 11/2021 - 11/2017
2	Operative Surgical Procedures 04/2020 - 01/2017
2	Nephrectomy 02/2020 - 01/2018
1	Immunotherapy 01/2021
1	Nephrotomy 04/2020
1	Percutaneous Nephrolithotomy 04/2020
1	Replantation 01/2020
1	Robotic Surgical Procedures 01/2019
1	Warm Ischemia 01/2018
1	Stents 10/2017
1	Lasers (Laser) 10/2017
1	Solid-State Lasers 10/2017